Mahummed Asif 
Product Recall in USA Pharmaceutical Industry – Complete Guide | PharmaShare Product Recall in USA Pharmaceutical Industry – Complete Regulatory Guide Product recalls are among the most significant quality events in the pharmaceutical industry. A recall can impact patient safety, regulatory compliance, company reputation, and financial performance. Every pharmaceutical manufacturer marketing products in the United … Read more
Best Practices for Conducting Qualitative Risk Assessments An effective qualitative risk assessment should be systematic, science-based, and consistently applied across the Pharmaceutical Quality System (PQS). Regulatory inspectors often review not only the outcome of a risk assessment but also the methodology, rationale, and supporting evidence used to arrive at the conclusions. Define a clear scope … Read more
Qualitative Risk Assessment Process A qualitative risk assessment should follow a structured and documented process to ensure consistency, transparency, and regulatory compliance. Although organizations may customize their approach, the methodology generally aligns with the Quality Risk Management (QRM) framework described in ICH Q9(R1). Step 1 – Define the Scope Clearly define the objective of the … Read more
Qualitative Risk Assessment in Pharma: Complete Guide to QRM, ICH Q9(R1), Risk Matrix & Examples (2026) Qualitative Risk Assessment in Pharma: Complete Guide to Quality Risk Management (ICH Q9(R1)) Every pharmaceutical process carries some degree of risk. Whether manufacturing tablets, qualifying equipment, validating a cleaning process, implementing a change control, or investigating a deviation, organizations … Read more
Best Practices for an Effective Change Management System A mature Change Management System goes beyond regulatory compliance. It promotes continuous improvement while ensuring product quality, patient safety, and data integrity are maintained. The following best practices are widely adopted by leading pharmaceutical manufacturers. Establish a clear and comprehensive Change Control SOP. Apply Quality Risk Management … Read more
Complete Change Control Workflow in Pharmaceutical Industry An effective Change Management System follows a structured workflow that ensures every proposed modification is scientifically evaluated before implementation. Although individual pharmaceutical companies may customize their procedures, the fundamental workflow remains largely consistent across the industry. Step 1: Change Request Initiation The process begins when a need for … Read more
Change Management System in Pharmaceutical Industry: Complete Guide (2026) Change Management System in Pharmaceutical Industry: Complete Guide (2026) The pharmaceutical industry operates in one of the most highly regulated environments in the world. Every modification made to a manufacturing process, facility, equipment, computer system, analytical method, supplier, packaging material, or documentation has the potential to … Read more
Revised Schedule M Guidelines (2025) – Complete GMP Compliance Guide for Pharmaceutical Manufacturers | PharmaShare Revised Schedule M Guidelines (2025) Complete GMP Compliance Guide for Pharmaceutical Manufacturers in India India’s pharmaceutical industry is one of the world’s largest suppliers of generic medicines. To ensure that medicines manufactured in India consistently meet global quality standards, the … Read more
DSCSA in Pharma – Complete Guide to the Drug Supply Chain Security Act (2026) DSCSA in Pharma – Complete Guide to the Drug Supply Chain Security Act (2026) Counterfeit medicines, diverted products, stolen drugs, and illegitimate pharmaceuticals pose serious risks to patient safety worldwide. To strengthen the integrity of the pharmaceutical supply chain in the … Read more
What is RFAR in Europe? RFAR stands for Rapid Field Alert Report. In EU terminology it’s directly linked to FSCA – Field Safety Corrective Action for medicinal products. Definition: An urgent communication to Competent Authorities and customers regarding actions taken to reduce risk of a defective medicinal product already on the market. Key EU Regulations … Read more
